Tango Therapeutics (TNGX) EBT Margin (2020 - 2025)

Tango Therapeutics' EBT Margin history runs 6 years deep, the most recent figure standing at 29.5% for Q3 2025.

• In Q3 2025, EBT Margin rose 28032.0% year-over-year to 29.5%; the TTM figure through Mar 2026 stood at 188.2% (up 13397.0% YoY), while the FY2025 annual figure was 162.85%, up 14639.0% from the prior year.
• EBT Margin was 29.5% for Q3 2025 at Tango Therapeutics, up from 1220.31% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 29.5% in Q3 2025 to a low of 1220.31% in Q2 2025.
• Historically, EBT Margin has averaged 412.22% across 5 years, with a median of 419.8% in 2022.
• The sharpest annual moves came in 2023 and 2025: EBT Margin surged 28926 bps in 2023, then sank 109208 bps in 2025.
• A 5-year view of EBT Margin shows it stood at 382.59% in 2021, then fell by 18 bps to 452.49% in 2022, then declined by 25 bps to 565.57% in 2023, then tumbled by 62 bps to 913.8% in 2024, then soared by 103 bps to 29.5% in 2025.
• The last three EBT Margin figures came in at 29.5% (Q3 2025), 1220.31% (Q2 2025), and 738.91% (Q1 2025), per Business Quant data.